524731 — Jenburkt Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹5.10bn
- IN₹4.59bn
- IN₹1.69bn
Annual cashflow statement for Jenburkt Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 223 | 246 | 260 | 321 | 347 |
| Depreciation | |||||
| Non-Cash Items | 34.3 | 44.6 | 62.9 | 60.6 | 34.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -182 | -143 | -265 | -129 | -148 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 94 | 171 | 81.2 | 279 | 265 |
| Capital Expenditures | -30.5 | -21 | -25.5 | -197 | -137 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 17.2 | 47.2 | 19.7 | 26.7 | -57.3 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -13.3 | 26.2 | -5.8 | -170 | -195 |
| Financing Cash Flow Items | -3.41 | -5.17 | -2.5 | -2.8 | -2.8 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -55.3 | -210 | -70.8 | -76.2 | -88.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 25.4 | -13.7 | 4.66 | 32.4 | -17.9 |